Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details Narrative)

v3.21.2
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Aug. 30, 2020
Jun. 24, 2020
Jun. 30, 2021
Sep. 30, 2020
Jun. 30, 2020
Proceeds from non-refundable upfront license fee $ 5,000,000.0        
Contract liabilities: deferred revenue, ending     $ 3,556,400    
Revenue     $ 354,100   $ 0
Weighted average exercise price     $ 7.00    
Research and development expense         15,000
General and administrative expense     $ 2,496,700   1,390,600
2019 Employee Stock Purchase Plan [Plan]          
Research and development expense     2,300   2,500
General and administrative expense     $ 2,700   $ 1,500
2019 Plan          
Option vested percentage     25.00%    
Common stock shares reserved for future issuance     1,311,279    
2019 Omnibus Equity Incentive Plan          
Stock options outstanding     575,000    
Employees          
Vesting percentages     25.00%    
PH94B [Member]          
Sublicense fees       $ 345,000  
Unregistered common stock issued for acquisition Costs   233,645      
Unregistered common stock issued for acquisition Costs, value   $ 125,000      
Acquisition Costs       $ 470,000  
Amortization of contract acquisition costs     $ 33,300    
2016 Equity Incentive Plan and 2019 Plan [Member]          
Weighted average exercise price     $ 1.39    
Stock options outstanding     15,071,639